期刊文献+

宫颈癌淋巴结转移的危险因素及预后分析 被引量:26

Risk factors and prognosis of node-positive cervical carcinoma
下载PDF
导出
摘要 目的:探讨宫颈癌盆腔淋巴结转移的危险因素以及淋巴结转移与患者预后的关系。方法:对328例行广泛性子宫切除及盆腔淋巴结清扫术的宫颈癌患者临床资料进行回顾性分析,应用单因素、多因素分析筛选淋巴结转移的危险因素,Kaplan—Meier法及Log-rank test作生存分析。结果:61例(18.60%)患者259枚淋巴结发生转移,单因素分析表明年龄、临床分期、病理分型、肌层浸润深度、脉管侵犯、分化程度与淋巴结转移相关;多因素分析提示临床分期、肌层浸润深度以及分化程度3个因素是淋巴结转移的独立危险因素。淋巴结转移数为1~2枚组和≥3枚组的5年生存率分别为53.1%和21.4%(P=0.018);单组淋巴结转移与多组淋巴结转移的5年生存率分别为48.8%和26.8%(P=0.025)。结论:宫颈癌盆腔淋巴结转移的主要危险因素是临床分期、肌层浸润深度以及细胞分化程度.受浸润淋巴结个数和组数越多,患者预后越差。 Objective: To investigate the risk factors and the correlation between lymph nodes metastasis and prognosis. Methods: Clinical datas of 328 cervical cancer patients undergone radical hysterectomy and bilateral pelvic lymphadenectomy were analysed retrospectively. Used univariate analysis and multivariate analysis to screen risk factors, made a survival analysis through Kaplan-Meier analysis and Log-rank test. Results: There were 61 (18.60%) node-positive cases. Univariate analysis showed that risk factors of lymph metastasis were age, clinical stage, pathological type, muscular infiltration, vessel involvement and differentiation grade. Multivariate analysis showed that clinical stage, muscular infiltration and differentiation grade were major risk factors. The 5-year survival rate of the group with 1 to 2 positive nodes and the group with more than 2 positive nodes were 53.1% and 21.4% respectively(P =0. 018). And the 5-year survival rate of the group with one node-positive site and the group with more than one node-positive site were 48.8% and 26.8% respectively(P = O. 025). Conclusion: The major risk factors of lymph nodes metastasis in cervical carcinoma are clinical stage, muscular infiltration and differentiation grade; with more positive nodes and more node-positive sites prognosis will be worse.
出处 《海南医学院学报》 CAS 2009年第5期475-477,481,共4页 Journal of Hainan Medical University
关键词 宫颈癌 淋巴结转移 危险因素 生存率 Cervical carcinoma Lymph nodes metastasis Risk factor Survival rate
  • 相关文献

参考文献9

  • 1林巧稚.妇科肿瘤学[M].北京:人民卫生出版社,1994.306~311.
  • 2Van Nageel Jv. Clinical invasive carcinoma of the cervix: clinical features diagnoses staging and pretreatment evaluation[ M]. New York: Chhurehkill Civingstone , 1992. 663.
  • 3Benedetti-Panici P, Maneschi F, D'Andrea G, et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study[J]. Cancer, 2000, 88( 10): 2267- 2274.
  • 4冯淑瑜,张彦娜,刘建刚.宫颈癌淋巴结转移的高危因素及预后分析[J].癌症,2005,24(10):1261-1266. 被引量:71
  • 5杨栓雀,邹红燕,张秀芳,赵西侠,金素娟.Ⅰ、Ⅱ期宫颈癌盆腔淋巴结转移危险因素分析[J].陕西肿瘤医学,2002,10(4):256-257. 被引量:11
  • 6蔡红兵.影响子宫颈癌盆腔淋巴结转移因素[J].肿瘤防治研究,2002,29(4):315-315. 被引量:6
  • 7Derescher GN. Comparison of the pattern of metastatic spreadof squamous cell cancer and adenocarcinoma of the uterin cervix[J]. Gynecol Oncol, 1989, 33(3): 340-343.
  • 8Monk BJ, Cha DS, Walker JL, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage Ⅰ b and Ⅱ a cervical carcinoma [J]. Gynecol Oncol, 1994,54( 1 ):4-9.
  • 9Tsai CS,Lai CH, Wang CC, et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy[J]. Gynecologic Oncology, 1999,75(3): 328-333.

二级参考文献20

  • 1陈亦乐,贺国强.ⅠⅡ期宫颈癌根治术后淋巴结转移与预后初探[J].实用癌症杂志,1995,10(1):42-43. 被引量:7
  • 2方素云,武昕.子宫颈癌(Ⅰ_a、—Ⅱ_b)术后淋巴结转移92例分析[J].实用肿瘤学杂志,1997,11(1):53-54. 被引量:6
  • 3李玲 程丽坤 等.I及II期宫颈癌根治术后淋巴结转移的病理与预后[J].中华妇产科杂志,1987,22(6):347-348.
  • 4Bolger BS, Dabbas M, Lopes A, et al. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma [J]. Gynecol Oncol,1997,65(2): 309-313.
  • 5Takeshima N, Hirai Y, Katase K, et al. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer [ J ]. Gynecol Oncol, 1998,68 (3): 263-266.
  • 6Monk B J, Cha DS, Walker JL, et al. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage Ⅰ B and Ⅱ A cervical carcinoma [J]. Gynecol Oncol,1994,54( 1 ): 4-9.
  • 7Scambia G, Ferrandina G, Distefano M, et al. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients? [J]. Gynecol Oncol, 2001,83(2):319-324.
  • 8Sakuragi N, Satoh C, Takeda N, et al. Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages Ⅰ B, Ⅱ A, and Ⅱ B cervical carcinoma treated with radical hysterectomy [J]. Cancer, 1999,85(7): 1547-1554.
  • 9Benedetti-Panici P, Maneschi F, D'Andrea G, et al. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study [J]. Cancer, 2000,88 (10):2267-2274.
  • 10Parazzini F, Valsecchi G, Bolis G, et al. Pelvic and paraortic lymph nodal status in advanced ovarian cancer and survival[ J]. Gynecol Oncol, 1999,74 ( 1 ): 7- 11.

共引文献84

同被引文献204

引证文献26

二级引证文献208

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部